American Massage Therapy Association
FDA Approved Drugs
American Massage Therapy Association
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 18
- Latest Approval Date Dec 12, 2025
- Data Source FDA
- First Approval Date Jan 06, 2020
Company Overview
Company
American Massage Therapy Association
Country
U.S.A
Website
Social Profiles
Company Snapshot
American Massage Therapy Association
500 Davis Street Suite 900 Evanston, IL 60201
U.S.A
www.amtamassage.org/ info@amtamassage.org View on MapFDA Approved Drug Records ( 18 records )
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
120MG
Approval Date
2023-03-07
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
216439
Product Number
1
Dosage Form
-
Strength
120MG
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
180MG
Approval Date
2023-03-07
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
216439
Product Number
2
Dosage Form
-
Strength
180MG
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
240MG
Approval Date
2023-03-07
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
216439
Product Number
3
Dosage Form
-
Strength
240MG
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
300MG
Approval Date
2023-03-07
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
216439
Product Number
4
Dosage Form
-
Strength
300MG
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
360MG
Approval Date
2023-03-07
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
216439
Product Number
5
Dosage Form
-
Strength
360MG
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
420MG
Approval Date
2023-03-07
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
216439
Product Number
6
Dosage Form
-
Strength
420MG
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
MESALAMINE
Product Number
1
Dosage Form
-
Strength
375MG
Approval Date
2023-06-06
Active Ingredient
MESALAMINE
Application Number
217533
Product Number
1
Dosage Form
-
Strength
375MG
Approval Date
2023-06-06
Regulatory Status
RX
Drug Name
NISOLDIPINE
Product Number
1
Dosage Form
-
Strength
8.5MG
Approval Date
2023-04-10
Active Ingredient
NISOLDIPINE
Application Number
216606
Product Number
1
Dosage Form
-
Strength
8.5MG
Approval Date
2023-04-10
Regulatory Status
RX
Drug Name
NISOLDIPINE
Product Number
2
Dosage Form
-
Strength
17MG
Approval Date
2025-12-12
Active Ingredient
NISOLDIPINE
Application Number
216606
Product Number
2
Dosage Form
-
Strength
17MG
Approval Date
2025-12-12
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2020-01-06
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
212026
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2020-01-06
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2020-01-06
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
212026
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2020-01-06
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
120MG
Approval Date
2020-01-06
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
212026
Product Number
3
Dosage Form
-
Strength
120MG
Approval Date
2020-01-06
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
160MG
Approval Date
2020-01-06
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
212026
Product Number
4
Dosage Form
-
Strength
160MG
Approval Date
2020-01-06
Regulatory Status
RX
Drug Name
TOPIRAMATE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2024-12-03
Active Ingredient
TOPIRAMATE
Application Number
218695
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2024-12-03
Regulatory Status
RX
Drug Name
TOPIRAMATE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2024-12-03
Active Ingredient
TOPIRAMATE
Application Number
218695
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2024-12-03
Regulatory Status
RX
Drug Name
TOPIRAMATE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2024-12-03
Active Ingredient
TOPIRAMATE
Application Number
218695
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2024-12-03
Regulatory Status
RX
Drug Name
TOPIRAMATE
Product Number
4
Dosage Form
-
Strength
150MG
Approval Date
2024-12-03
Active Ingredient
TOPIRAMATE
Application Number
218695
Product Number
4
Dosage Form
-
Strength
150MG
Approval Date
2024-12-03
Regulatory Status
RX
Drug Name
TOPIRAMATE
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2024-12-03
Active Ingredient
TOPIRAMATE
Application Number
218695
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2024-12-03
Regulatory Status
RX
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
18 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
18 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
DILTIAZEM HYDROCHLORIDE
Application Number
216439
Product Number
1
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Dosage Form
-
Strength
120MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.